Suchergebnisse - "TK8ERE8P56"

PubPharm (361)

1

Cardiovascular complications of ribociclib in breast cancer patients

enthalten in: Critical reviews in oncology/hematology | 2024

von Fiste, O. | Mavrothalassitis, E. | Apostolidou, K. | +8

2

Anti-Cancer Effects of CDK4/6 Inhibitor LEE011 and Chemotherapy Drugs on Lymphocytic Leukemia L1210 Cells

enthalten in: Anticancer research | 2024

von Lin, Y. | Lin, Y. | Chang, Y. | +4

3

Ribociclib plus Endocrine Therapy in Early Breast Cancer

enthalten in: The New England journal of medicine | 2024

von Slamon, D. | Lipatov, O. | Nowecki, Z. | +28

4

First-line CDK4/6 inhibitor-based combinations for HR+/HER2- advanced breast cancer : A Bayesian network meta-analysis

enthalten in: Journal of evidence-based medicine | 2024

von Guo, X. | Zhou, Y. | Zhang, K. | +6

5

A low-cost voltammetric sensor based on multi-walled carbon nanotubes for highly sensitive and accurate determination of nanomolar levels of the anticancer drug Ribociclib in bulk and biological fluids

enthalten in: Analytical methods : advancing methods and applications | 2024

von Bouali, W. | Erk, N. | Genc, A.

6

Liver toxicity with ribociclib in a patient with metastatic hormone receptor positive postmenopausal breast cancer

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Sozer Karadagli, S. | Gursoy, P.

7

Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole : Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Fasching, P. | Decker, T. | Hartkopf, A. | +18

8

Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2- Breast Cancer Treated with Ribociclib and ET : Correlative Analysis of MONALEESA-2, -3, -7

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Prat, A. | Solovieff, N. | André, F. | +12

9

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients : a Turkish oncology group (TOG) study

enthalten in: International journal of clinical oncology | 2024

von Yıldırım, H. | Kutlu, Y. | Mutlu, E. | +31

10

Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer

enthalten in: Scientific reports | 2024

von Kappel, C. | Elliott, M. | Kumar, V. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]